Art

J-GLOBAL ID：201902272181974179   Reference number：19A0153412

Effect of luseogliflozin on hepatic fat content in type 2 diabetes patients with non-alcoholic fatty liver disease: A prospective, single-arm trial (LEAD trial)

非アルコール性脂肪肝疾患の2型糖尿病患者における肝脂肪含量に対するルセオグリフロジンの効果:前向き単群試験(鉛試験)

Author (7)： Sumida Yoshio (Division of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University, Aichi, Japan) ,  Murotani Kenta (Biostatistics Center, Graduate School of Medicine, Kurume University, Fukuoka, Japan) ,  Saito Miyoko (Nakakinen Clinic Medical Corporation Kenseikai, Ibaraki, Japan) ,  Tamasawa Atsuko (Nakakinen Clinic Medical Corporation Kenseikai, Ibaraki, Japan) ,  Osonoi Yusuke (Nakakinen Clinic Medical Corporation Kenseikai, Ibaraki, Japan) ,  Yoneda Masashi (Division of Hepatology and Pancreatology, Department of Internal Medicine, Aichi Medical University, Aichi, Japan) ,  Osonoi Takeshi (Nakakinen Clinic Medical Corporation Kenseikai, Ibaraki, Japan)
Material： Hepatology Research  (Hepatol Res)
Volume： 49  Issue： 1  Page： 64-71  Publication year： Jan. 2019 
JST Material Number： W1284A  ISSN： 1386-6346  Document type： Article
Article type： 原著論文  Country of issue： Australia (AUS)  Language： ENGLISH (EN)

Thesaurus term： human(primates) ,...
Semi thesaurus term： *Non alcoholic fatty liver disease ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0153412&from=J-GLOBAL&jstjournalNo=W1284A") }}

Author keywords (4)： luseogliflozin ,  non-alcoholic fatty liver disease ,  steatosis ,  type 2 diabetes

JST classification (3)： Digestive system diseases  (GH03000W) ,  Treatment for metabolic diseases,nutritional diseases.  (GD05030F) ,  Clinical application of drugs acting on carbohydrate metabolism  (GW13030B)

Substance index (1)： Luseogliflozin

Terms in the title (7)： 非アルコール性脂肪肝疾患 ,  2型糖尿病 ,  患者 ,  脂肪含量 ,  ルセオグリフロジン ,  試験 ,  鉛